HUP0102676A2 - Szilárd, gyorsan széteső cetirizint tartalmazó gyógyszerkészítmények - Google Patents

Szilárd, gyorsan széteső cetirizint tartalmazó gyógyszerkészítmények

Info

Publication number
HUP0102676A2
HUP0102676A2 HU0102676A HUP0102676A HUP0102676A2 HU P0102676 A2 HUP0102676 A2 HU P0102676A2 HU 0102676 A HU0102676 A HU 0102676A HU P0102676 A HUP0102676 A HU P0102676A HU P0102676 A2 HUP0102676 A2 HU P0102676A2
Authority
HU
Hungary
Prior art keywords
solid
cetirizine
cetrizine
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU0102676A
Other languages
English (en)
Inventor
Mario André Piskernig
Wolfram Tritthart
Original Assignee
Asta Medica Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Aktiengesellschaft filed Critical Asta Medica Aktiengesellschaft
Publication of HUP0102676A2 publication Critical patent/HUP0102676A2/hu
Publication of HUP0102676A3 publication Critical patent/HUP0102676A3/hu
Publication of HU227477B1 publication Critical patent/HU227477B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Abstract

A találmány tárgyát szilárd, gyorsan széteső cetirizinpezsgőkészítmények képezik, oldható tabletták, diszpergálhatótabletták vagy granulátumok alakjában. A cetirizin egy antiallergiásés görcsoldó tulajdonságokkal rendelkező 4-(difenil-metil)-piperidino-alkoxi-ecetsav származék. A találmány szerinti orálisan alkalmazható,cetirizint vagy gyógyászatilag elfogadható sóit, egy pezsgőalapot -amely legalább egy ehető szerves savat és/vagy ennek sóit, alkáli-és/vagy alkáli földfém-karbonátokat tartalmaz - és adott esetbengyógyászatilag alkalmazható segédanyagokat tartalmazó szilárd, gyorsanszéteső pezsgőkészítmények lehetővé teszik a hatóanyag kellemetlenízének kiküszöbölését. Ó
HU0102676A 1998-03-31 1999-03-20 Solid, quick dissolving pharmaceutical compositions containing cetrizine HU227477B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19814256A DE19814256A1 (de) 1998-03-31 1998-03-31 Feste, schnellzerfallende Cetirizin-Formulierungen
PCT/DE1999/000799 WO1999049843A1 (de) 1998-03-31 1999-03-20 Feste, schnellzerfallende cetirizin-formulierungen

Publications (3)

Publication Number Publication Date
HUP0102676A2 true HUP0102676A2 (hu) 2001-11-28
HUP0102676A3 HUP0102676A3 (en) 2002-12-28
HU227477B1 HU227477B1 (en) 2011-07-28

Family

ID=7863014

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102676A HU227477B1 (en) 1998-03-31 1999-03-20 Solid, quick dissolving pharmaceutical compositions containing cetrizine

Country Status (31)

Country Link
US (1) US6245353B1 (hu)
EP (1) EP1067904B1 (hu)
JP (1) JP2002509873A (hu)
KR (1) KR100653568B1 (hu)
CN (1) CN1136838C (hu)
AR (1) AR018828A1 (hu)
AT (1) ATE209899T1 (hu)
AU (1) AU750140B2 (hu)
BG (1) BG64741B1 (hu)
BR (1) BR9909233A (hu)
CA (1) CA2326809C (hu)
CY (1) CY1107331T1 (hu)
CZ (1) CZ300704B6 (hu)
DE (2) DE19814256A1 (hu)
DK (1) DK1067904T3 (hu)
ES (1) ES2168013T3 (hu)
HK (1) HK1036217A1 (hu)
HU (1) HU227477B1 (hu)
IL (1) IL138606A (hu)
NO (1) NO329071B1 (hu)
NZ (1) NZ506988A (hu)
PL (1) PL191266B1 (hu)
PT (1) PT1067904E (hu)
RU (1) RU2216318C2 (hu)
SI (1) SI1067904T1 (hu)
SK (1) SK284476B6 (hu)
TR (1) TR200002809T2 (hu)
TW (1) TWI233808B (hu)
UA (1) UA57615C2 (hu)
WO (1) WO1999049843A1 (hu)
ZA (1) ZA200005134B (hu)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1302201A4 (en) * 2000-07-17 2007-09-05 Astellas Pharma Inc PHARMACEUTICAL COMPOSITION WITH IMPROVED ABSORBABILITY
WO2003059328A1 (en) 2002-01-15 2003-07-24 Ucb Farchim, S.A. Formulations
DE60319685T2 (de) * 2002-04-04 2009-03-26 Pfizer Products Inc., Groton Wohlschmeckende kautablette
US20080287456A1 (en) * 2004-05-28 2008-11-20 Imaginot Pty Ltd Oral Therapeutic Compound Delivery System
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
CA2588338C (en) 2004-11-24 2013-05-28 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US20060198885A1 (en) * 2005-02-22 2006-09-07 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical composition
EP1954298A4 (en) 2005-11-28 2012-10-31 Imaginot Pty Ltd DISPENSING SYSTEM FOR ORAL THERAPEUTIC CONNECTION
CN102143737A (zh) * 2008-09-05 2011-08-03 麦克内尔-Ppc股份有限公司 制备西替利嗪片剂的方法
EP2405747A4 (en) * 2009-03-13 2013-01-16 Nucitec Sa De Cv COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES
WO2011146032A2 (en) * 2010-05-18 2011-11-24 Mahmut Bilgic Effervescent formulations
CN104363897A (zh) 2012-06-12 2015-02-18 宝洁公司 泡腾剂型
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
JP5945191B2 (ja) * 2012-08-09 2016-07-05 株式会社ファンケル 口腔内速崩錠
JP6092672B2 (ja) * 2013-03-21 2017-03-08 株式会社ファンケル 口腔内速崩壊性錠剤
KR101591319B1 (ko) * 2013-12-03 2016-02-18 에프엔바이오 주식회사 홍삼 발포정의 제조방법
TWI732337B (zh) * 2014-06-20 2021-07-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
CN106109422A (zh) * 2016-07-28 2016-11-16 北京万全德众医药生物技术有限公司 盐酸左西替利嗪泡腾颗粒及其制备方法
US10624921B2 (en) 2016-11-15 2020-04-21 Berkeley Nox Limited Dietary supplements
JP2018108950A (ja) * 2016-12-28 2018-07-12 沢井製薬株式会社 レボセチリジン塩酸塩含有口腔内崩壊錠
WO2019099003A2 (en) * 2017-11-15 2019-05-23 Berkeley Nox Limited Novel dietary supplements
ES2945809T3 (es) 2019-10-02 2023-07-07 Intas Pharmaceuticals Ltd Composiciones farmacéuticas sólidas efervescentes prácticamente sin sodio

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
US4792448A (en) * 1987-06-11 1988-12-20 Pfizer Inc. Generic zero order controlled drug delivery system
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
DK0542926T3 (da) * 1990-08-07 1995-05-15 Pfizer Brug af grænsefladepolymeriserede membraner i frigivelsesanordninger
ATE195417T1 (de) * 1991-05-13 2000-09-15 Boots Co Plc Ibuprofen-salz enthaltende pharmazeutische zusammensetzung
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
NZ256346A (en) * 1992-10-09 1997-04-24 Procter & Gamble Medicaments containing 3-l-menthoxypropane-1,2-diol for treating cold symptoms
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
FR2698788B1 (fr) * 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
DE59400446D1 (de) * 1993-04-15 1996-08-29 Gergely Gerhard Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen Wirkstoff, und Verfahren zur Herstellung
EP0695175A1 (en) * 1993-04-30 1996-02-07 The Procter & Gamble Company Coated pharmaceutical compositions
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions

Also Published As

Publication number Publication date
CZ20003481A3 (en) 2001-05-16
CA2326809C (en) 2008-11-18
ATE209899T1 (de) 2001-12-15
KR100653568B1 (ko) 2006-12-05
WO1999049843A1 (de) 1999-10-07
SK14312000A3 (sk) 2001-07-10
BG64741B1 (bg) 2006-02-28
RU2216318C2 (ru) 2003-11-20
ZA200005134B (en) 2000-12-21
PL191266B1 (pl) 2006-04-28
KR20010034718A (ko) 2001-04-25
HK1036217A1 (en) 2001-12-28
CN1136838C (zh) 2004-02-04
UA57615C2 (uk) 2003-06-16
BG104843A (en) 2001-07-31
NO20004722D0 (no) 2000-09-21
EP1067904A1 (de) 2001-01-17
CZ300704B6 (cs) 2009-07-22
CA2326809A1 (en) 1999-10-07
AU750140B2 (en) 2002-07-11
CY1107331T1 (el) 2012-12-19
EP1067904B1 (de) 2001-12-05
IL138606A (en) 2005-07-25
CN1295464A (zh) 2001-05-16
SK284476B6 (sk) 2005-04-01
AR018828A1 (es) 2001-12-12
HU227477B1 (en) 2011-07-28
AU3925399A (en) 1999-10-18
TR200002809T2 (tr) 2000-12-21
NO20004722L (no) 2000-09-21
PT1067904E (pt) 2002-05-31
ES2168013T3 (es) 2002-05-16
IL138606A0 (en) 2001-10-31
NO329071B1 (no) 2010-08-16
DE59900501D1 (de) 2002-01-17
US6245353B1 (en) 2001-06-12
PL343199A1 (en) 2001-07-30
NZ506988A (en) 2002-05-31
JP2002509873A (ja) 2002-04-02
DE19814256A1 (de) 1999-10-07
DK1067904T3 (da) 2002-04-02
BR9909233A (pt) 2000-11-28
HUP0102676A3 (en) 2002-12-28
TWI233808B (en) 2005-06-11
SI1067904T1 (en) 2002-04-30

Similar Documents

Publication Publication Date Title
HUP0102676A2 (hu) Szilárd, gyorsan széteső cetirizint tartalmazó gyógyszerkészítmények
EP1863443B1 (en) Rapidly disintegrating dosage form comprising magnesium carbonate heavy
WO2001087264A3 (en) Rapidly disintegrating solid oral dosage form
WO2004000197A3 (en) Quick dissolve compositions and tablets based thereon
AR018143A1 (es) Formulacion para preparar un comprimido de desintegracion rapida, comprimidos de desintegracion rapida, especialmente comprimidos de desintegracionrapida en la boca
ES2164424T3 (es) Preparacion farmaceutica solida.
WO2007009806A3 (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption
WO2004069198A3 (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
BR9503386A (pt) Formulaçao farmacêutica comprimido dispersivel e processo para a fabricaçao de comprimidos dispersíveis contendo cloridrato de fluoxetina
HUP0302131A2 (hu) Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények
WO2003047519A3 (en) 'compressed annular tablet with molded triturate tablet for oral and intraoral'
HUP0302086A2 (hu) Késleltetett hatású orális gyógyászati készítmény és eljárás az előállítására
HUP0004383A2 (hu) Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény
NZ591443A (en) Granule formation of pirfenidone and pharmaceutically acceptable excipients
HUP0203312A3 (en) Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use
WO2000021510A3 (en) Formulations of fexofenadine
PE20030950A1 (es) Comprimido masticable con sabor agradable
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
HUP0301390A2 (hu) Valzartánt tartalmazó orális gyógyászati készítmény
EP2138175A3 (en) Formulations comprising valsartan for treating diabetes or microalbuminuria
HUP0500842A2 (hu) Dronedaront tartalmazó gyógyászati készítmény parenterális adagolásra
WO2004071156A3 (en) Use of edible acid in fast-dispersing pharmaceutical solid dosage forms
HUP0303178A2 (hu) Eljárások és készítmények gyógyászatilag aktív anyagok ízének csökkentésére
WO2001026621A3 (en) Orally distintegrating composition comprising mirtazapine
EP1411956B8 (en) Use of oversulfated polysaccharides as inhibitors of hiv

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: MEDA PHARMA GMBH & CO. KG, DE

Free format text: FORMER OWNER(S): ASTA MEDICA AKTIENGESELLSCHAFT, DE; ASTA MEDICA HEALTH PRODUCTS GMBH & CO. KG, DE; VIATRIS GMBH & CO. KG, DE; VIATRIS GMBH & CO. KG, DE

MM4A Lapse of definitive patent protection due to non-payment of fees